Taiwan
· Delayed Price · Currency is TWD AP Biosciences Statistics
Total Valuation
AP Biosciences has a market cap or net worth of TWD 4.54 billion. The enterprise value is 3.07 billion.
| Market Cap | 4.54B |
| Enterprise Value | 3.07B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AP Biosciences has 85.11 million shares outstanding. The number of shares has increased by 16.28% in one year.
| Current Share Class | 85.11M |
| Shares Outstanding | 85.11M |
| Shares Change (YoY) | +16.28% |
| Shares Change (QoQ) | +29.58% |
| Owned by Insiders (%) | 6.38% |
| Owned by Institutions (%) | 10.79% |
| Float | 46.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.44 |
Financial Position
The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.04.
| Current Ratio | 39.87 |
| Quick Ratio | 39.77 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.20 |
| Interest Coverage | -266.42 |
Financial Efficiency
Return on equity (ROE) is -35.13% and return on invested capital (ROIC) is -21.44%.
| Return on Equity (ROE) | -35.13% |
| Return on Assets (ROA) | -20.96% |
| Return on Invested Capital (ROIC) | -21.44% |
| Return on Capital Employed (ROCE) | -26.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -11.43M |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -8.47% |
| 50-Day Moving Average | 49.62 |
| 200-Day Moving Average | 52.22 |
| Relative Strength Index (RSI) | 54.39 |
| Average Volume (20 Days) | 40,515 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -439.06M |
| Pretax Income | -422.75M |
| Net Income | -422.75M |
| EBITDA | -433.93M |
| EBIT | -439.06M |
| Earnings Per Share (EPS) | -5.61 |
Balance Sheet
The company has 1.54 billion in cash and 70.91 million in debt, giving a net cash position of 1.47 billion or 17.28 per share.
| Cash & Cash Equivalents | 1.54B |
| Total Debt | 70.91M |
| Net Cash | 1.47B |
| Net Cash Per Share | 17.28 |
| Equity (Book Value) | 1.62B |
| Book Value Per Share | 19.09 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was -357.88 million and capital expenditures -5.53 million, giving a free cash flow of -363.41 million.
| Operating Cash Flow | -357.88M |
| Capital Expenditures | -5.53M |
| Free Cash Flow | -363.41M |
| FCF Per Share | -4.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AP Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.28% |
| Shareholder Yield | n/a |
| Earnings Yield | -9.32% |
| FCF Yield | -8.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |